OraSure Technologies, Inc. OSUR
3.53 USD +0.09 (+2.62%)
At closeNov 9, 2026, 7:24 PM EST
3.51 -0.02 -0.46%
After hours · Nov 9, 7:24 PM ET
3.42 Day range 3.62
2.08 52-week range 4.58
- YTD
- +45.87%
- 1 year
- +47.08%
News
benzinga.com OraSure Technologies Q3 2026 Earnings Call Transcript OraSure Technologies (NASDAQ:OSUR) reported third-quarter financial results on Monday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought…
benzinga.com OraSure Technologies Sees Q4 Sales $30.000M-$32.000M vs $31.701M Est OraSure Technologies (NASDAQ:OSUR) sees Q4 sales of $30.000 million-$32.000 million vs $31.701 million analyst estimate.
benzinga.com OraSure Technologies Q3 Adj. EPS $(0.15) Beats $(0.20) Estimate, Sales $30.907M Miss $31.021M Estimate OraSure Technologies (NASDAQ:OSUR) reported quarterly losses of $(0.15) per share which beat the analyst consensus estimate of $(0.20) by 25 percent. This is a 15.38 percent decrease over losses of…
globenewswire.com OraSure Technologies Joins the World Coalition on Sickle Cell Disease to Advance Access to Earlier Diagnosis and Care Collaboration will bring diagnostics expertise to a global, multi-stakeholder effort focused on policy, advocacy, and practical implementation Collaboration will bring diagnostics expertise to a…
benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session Gainers IM Cannabis (NASDAQ:IMCC) stock rose 108.5% to $3.63 during Friday's pre-market session. The market value of their outstanding shares is at $1.0 million. Alaunos Therapeutics (NASDAQ:TCRT)…
benzinga.com World Health Organization Director General Determined That The Ebola Epidemic In DRC Still Meets Criteria Of Public Health Emergency Of International Concern, But Not Those Of A Pandemic Emergency https://www.who.int/news/item/28-08-2026-second-meeting-of-the-ihr-emergency-committee-on-the-epidemic-of-ebola-bundibugyo-virus-disease-in-the-democratic-republic-of-the-congo---meeting-report
benzinga.com OraSure Technologies Sees Q3 Sales $29.500M-$32.500M vs $31.143M Est OraSure Technologies (NASDAQ:OSUR) sees Q3 sales of $29.500 million-$32.500 million vs $31.143 million analyst estimate.- benzinga.com OraSure Technologies Receives FDA's Emergency Use Authorization For Its OraQuick Ebola 2.0 Rapid Antigen Test OraSure Technologies, Inc. (NASDAQ:OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies, announced today that it has received Emergency Use…
benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session 
benzinga.com Earnings Scheduled For May 6, 2026 
benzinga.com OraSure Technologies Sees Q2 Sales $27.000M-$30.000M vs $29.098M Est OraSure Technologies (NASDAQ:OSUR) sees Q2 sales of $27.000 million-$30.000 million vs $29.098 million analyst estimate.
benzinga.com OraSure Technologies Q1 Adj. EPS $(0.24) Misses $(0.23) Estimate, Sales $27.925M Beat $27.707M Estimate OraSure Technologies (NASDAQ:OSUR) reported quarterly losses of $(0.24) per share which missed the analyst consensus estimate of $(0.23) by 4.35 percent. This is a 33.33 percent decrease over losses…- benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session
benzinga.com Altai Capital Presses OraSure Board For Overhaul, Nominates Two Directors Altai Capital urges board changes at OraSure, citing underperformance, governance concerns, and misaligned CEO compensation.- benzinga.com OraSure Defends Strategy Amid Altai Proxy Push; Highlights 2026 Regulatory, Commercial Milestones And Shareholder Value Initiatives Company Has Demonstrated Momentum on Transformation Strategy with Significant Regulatory and Commercial Milestones Approaching in 2026Highlights Extensive Engagement with AltaiAltai Has Rejected All…
benzinga.com 'Altai Vows To Press On With Proxy Fight If Orasure Does Not Offer Board Seats; Investor Altai Capital Calls On Orasure Technologies To Put Itself Up For Sale, Letter Says' - Reuters Exclusive Altai says OraSure is worth more sold than operating as a standalone companyAltai pressing for board seats after nominating two directors in JanuaryAltai says board failed to prevent missteps, pushes…- benzinga.com OraSure Technologies Sees Q1 Sales $26.000M-$29.000M vs $28.599M Est OraSure Technologies (NASDAQ:OSUR) sees Q1 sales of $26.000 million-$29.000 million vs $28.599 million analyst estimate.
benzinga.com OraSure Technologies: Q4 Earnings Insights - benzinga.com OraSure Technologies Q4 Adj. EPS $(0.19) Beats $(0.20) Estimate, Sales $26.763M Beat $26.443M Estimate OraSure Technologies (NASDAQ:OSUR) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.20) by 7.32 percent. This is a 216.67 percent decrease over losses…
- benzinga.com Earnings Scheduled For February 25, 2026
- benzinga.com OraSure Technologies Announced Its OraQuick HIV Self-Test Has Received License From Health Canada The OraQuick™ HIV Self-Test is a point-of-care rapid antibody test. It is Canada's first oral HIV self-test and detects antibodies for both HIV-1 and HIV-2, enabling individuals to find out their HIV…
benzinga.com OraSure Submits Two Separate Applications At 2025 End To FDA For Clearance Of Rapid Molecular Self-Test For CT/NG As Well As Colli-Pee At-Home Urine Collection Device For STIs OraSure Technologies, Inc. (NASDAQ:OSUR) ("OraSure" and "OTI"), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced that it submitted two separate…- benzinga.com Stephens & Co. Maintains Equal-Weight on OraSure Technologies, Lowers Price Target to $3 Stephens & Co. analyst Steven Etoch maintains OraSure Technologies (NASDAQ:OSUR) with a Equal-Weight and lowers the price target from $3.5 to $3.
- benzinga.com OraSure Technologies Sees Q4 Sales $25.000M-$28.000M vs $31.180M Est Financial GuidanceThe Company is guiding to Q4 2025 Total revenues of $25 million to $28 million, which includes less than $100 thousand of COVID-19 testing revenues.
- benzinga.com OraSure Technologies Q3 Adj. EPS $(0.13) Beats $(0.20) Estimate, Sales $27.085M Miss $28.960M Estimate OraSure Technologies (NASDAQ:OSUR) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.20) by 35 percent. This is a 1200 percent decrease over losses of…
benzinga.com Earnings Scheduled For November 5, 2025 - benzinga.com "Healthcare Entrepreneur Ron Zwanziger Threatens 'Adversarial Path' For Orasure Technologies After Company Rebuffs Takeover Bid, Letter Says" - Reuters Exclusive Orasure stock price has dropped 11% in 4 weeks, 32% in 12 monthsZwanziger offered $3.50-$4 a share, price now under $3/shareOrasure Tech makes COVID-19 rapid-antigen testsLetter says $40 million…
benzinga.com OraSure Technologies Sees Q3 Sales $27.000M-$30.000M vs $33.15M Est OraSure Technologies (NASDAQ:OSUR) sees Q3 sales of $27.000 million-$30.000 million vs $33.15 million analyst estimate.- benzinga.com OraSure Technologies Q2 Adj. EPS $(0.19) Beats $(0.20) Estimate, Sales $31.24M Beat $30.52M Estimate OraSure Technologies (NASDAQ:OSUR) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.20) by 7.32 percent. This is a 371.43 percent decrease over earnings…
- benzinga.com Earnings Scheduled For August 5, 2025
- benzinga.com Evercore ISI Group Maintains In-Line on OraSure Technologies, Maintains $3 Price Target Evercore ISI Group analyst Vijay Kumar maintains OraSure Technologies (NASDAQ:OSUR) with a In-Line and maintains $3 price target.
- benzinga.com OraSure Technologies Sees Q2 Sales $28.500M-$32.500M vs $32.96M Est OraSure Technologies (NASDAQ:OSUR) sees Q2 sales of $28.500 million-$32.500 million vs $32.96 million analyst estimate.
- benzinga.com OraSure Technologies Q1 Adj. EPS $(0.18) Beats $(0.20) Estimate, Sales $29.93M Beat $29.18M Estimate OraSure Technologies (NASDAQ:OSUR) reported quarterly losses of $(0.18) per share which beat the analyst consensus estimate of $(0.20) by 10 percent. This is a 550 percent decrease over earnings of…
- benzinga.com Earnings Scheduled For May 7, 2025
- benzinga.com OraSure Technologies Sees Q1 Sales $27.500M-$31.500M vs $32.38M Est OraSure Technologies (NASDAQ:OSUR) sees Q1 sales of $27.500 million-$31.500 million vs $32.38 million analyst estimate.
- benzinga.com OraSure Technologies Q4 Adj $(0.06), Inline, Sales $37.45M Beat $36.72M Estimate OraSure Technologies (NASDAQ:OSUR) reported quarterly losses of $(0.06) per share which met the analyst consensus estimate. This is a 133.33 percent decrease over earnings of $0.18 per share from the…
- benzinga.com Earnings Scheduled For February 25, 2025
- benzinga.com Earnings Scheduled For February 27, 2024 Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on revenue of $100.49 million.
benzinga.com Earnings Scheduled For November 7, 2023 Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings for its third quarter.- benzinga.com Why ResMed Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session Gainers Missfresh Limited (NASDAQ: MF) jumped 168% to $1.38 after the company announced entry of share purchase agreements for financing and business acquisition.
- benzinga.com Atlassian, Universal Display, Booking, Dropbox And Other Big Stocks Moving Higher On Friday U.S. stocks traded higher, with the Dow Jones gaining around 150 points on Friday. Here are some big stocks recording gains in today’s session.
- benzinga.com Earnings Scheduled For August 3, 2023 Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings at $1.10 per share on revenue of $512.74 million.
- benzinga.com Why Venus Concept Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session Gainers NeoGames S.A. (NASDAQ: NGMS) shares climbed 113.3% to $27.38 as the company agreed to be acquired by Aristocrat Leisure Limited for $29.50 per share in cash.
- benzinga.com Earnings Scheduled For May 10, 2023 Companies Reporting Before The Bell • Nomad Foods (NYSE:NOMD) is projected to report quarterly earnings at $0.42 per share on revenue of $851.81 million.
- benzinga.com Why Sabre Are Trading Lower By 19%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session Gainers Sera Prognostics, Inc. (NASDAQ: SERA) shares surged 63.4% to $2.11 after the company announced top-line data from the AVERT PRETERM TRIAL.
- benzinga.com Trade Desk, Roblox, Herbalife And Other Big Stocks Moving Higher On Wednesday U.S. stocks traded lower, with the Dow Jones dropping over 150 points on Wednesday. Here are some big stocks recording gains in today’s session.
- benzinga.com Earnings Scheduled For February 14, 2023 Companies Reporting Before The Bell • WESCO International (NYSE:WCC) is projected to report quarterly earnings at $3.79 per share on revenue of $5.37 billion.
- benzinga.com Earnings Scheduled For November 8, 2022 Companies Reporting Before The Bell • Adtran (NASDAQ:ADTN) is likely to report quarterly earnings at $0.18 per share on revenue of $330.39 million.
- benzinga.com Earnings Scheduled For August 9, 2022 Companies Reporting Before The Bell • Cognition Therapeutics (NASDAQ:CGTX) is estimated to report earnings for its second quarter.
- benzinga.com Stocks That Hit 52-Week Lows On Monday During Monday's trading, 1214 companies set new 52-week lows.